MA41985B1 - Composition pour le nettoyage du côlon et le traitement de troubles gastro-intestinaux - Google Patents

Composition pour le nettoyage du côlon et le traitement de troubles gastro-intestinaux

Info

Publication number
MA41985B1
MA41985B1 MA41985A MA41985A MA41985B1 MA 41985 B1 MA41985 B1 MA 41985B1 MA 41985 A MA41985 A MA 41985A MA 41985 A MA41985 A MA 41985A MA 41985 B1 MA41985 B1 MA 41985B1
Authority
MA
Morocco
Prior art keywords
gastrointestinal disorders
cleansing
colon
composition
treating gastrointestinal
Prior art date
Application number
MA41985A
Other languages
English (en)
Other versions
MA41985A (fr
Inventor
Mark Currie
Robert Solinga
Christopher Leitheiser
Original Assignee
Ironwood Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ironwood Pharmaceuticals Inc filed Critical Ironwood Pharmaceuticals Inc
Publication of MA41985A publication Critical patent/MA41985A/fr
Publication of MA41985B1 publication Critical patent/MA41985B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La présente invention propose des peptides et des compositions qui sont utiles pour le traitement de troubles gastro-intestinaux ou pour le nettoyage du côlon. La présente invention concerne également des compositions et des procédés de traitement de troubles gastro-intestinaux et des compositions pharmaceutiques pour accomplir ceux-ci. Dans certains modes de réalisation, ces compositions pharmaceutiques comprennent des formes posologiques orales. (71) us:ironwood pharmaceuticals, inc.@100 summer street, suite 2300 boston, ma 02110@
MA41985A 2015-05-01 2016-04-29 Composition pour le nettoyage du côlon et le traitement de troubles gastro-intestinaux MA41985B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562156077P 2015-05-01 2015-05-01
PCT/US2016/030061 WO2016178979A1 (fr) 2015-05-01 2016-04-29 Composition pour le nettoyage du côlon et le traitement de troubles gastro-intestinaux

Publications (2)

Publication Number Publication Date
MA41985A MA41985A (fr) 2018-03-07
MA41985B1 true MA41985B1 (fr) 2023-04-28

Family

ID=55953439

Family Applications (1)

Application Number Title Priority Date Filing Date
MA41985A MA41985B1 (fr) 2015-05-01 2016-04-29 Composition pour le nettoyage du côlon et le traitement de troubles gastro-intestinaux

Country Status (23)

Country Link
US (2) US10618938B2 (fr)
EP (2) EP4218789A3 (fr)
JP (4) JP6930919B2 (fr)
KR (2) KR20250042844A (fr)
CN (2) CN114716514A (fr)
CA (2) CA2984437C (fr)
CY (1) CY1126031T1 (fr)
DK (1) DK3288578T5 (fr)
EA (1) EA201792401A1 (fr)
ES (1) ES2947591T3 (fr)
FI (1) FI3288578T3 (fr)
HR (1) HRP20230381T1 (fr)
HU (1) HUE061954T2 (fr)
LT (1) LT3288578T (fr)
MA (1) MA41985B1 (fr)
MD (1) MD3288578T2 (fr)
MX (2) MX2017013928A (fr)
PL (1) PL3288578T3 (fr)
PT (1) PT3288578T (fr)
RS (1) RS64160B1 (fr)
SI (1) SI3288578T1 (fr)
SM (1) SMT202300114T1 (fr)
WO (1) WO2016178979A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20220479T1 (hr) 2016-06-01 2022-05-27 Athira Pharma, Inc. Spojevi
AU2022396412A1 (en) * 2021-11-24 2024-05-30 Ironwood Pharmaceuticals, Inc. Synthetic process for production of modified gcc receptor agonists
US20250197449A1 (en) * 2021-11-24 2025-06-19 Ironwood Pharmaceuticals, Inc. Synthetic Process for Production of Modified GCC Receptor Agonists
KR20240111797A (ko) 2021-11-29 2024-07-17 아이언우드 파마슈티컬스, 인코포레이티드 내장 통증의 치료를 위한 제약 조성물
WO2026050206A1 (fr) * 2024-08-27 2026-03-05 Ironwood Pharmaceuticals, Inc. Combinaisons d'agonistes du récepteur de glp-1 et de guanylate cyclase c (gc-c)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH689139A5 (de) 1995-04-03 1998-10-30 Cerbios Pharma Sa Verfahren zur Herstellung einer liposomalen, in Wasser dispergierbaren, oral zu verabreichenden, festen, trockenen therapeutischen Formulierung.
US5912014A (en) 1996-03-15 1999-06-15 Unigene Laboratories, Inc. Oral salmon calcitonin pharmaceutical products
ATE477268T1 (de) * 2003-01-28 2010-08-15 Ironwood Pharmaceuticals Inc Zusammensetzungen zur behandlung von magen-darm- störungen
US7494979B2 (en) * 2003-06-13 2009-02-24 Ironwood Pharmaceuticals, Inc. Method for treating congestive heart failure and other disorders
WO2007022531A2 (fr) * 2005-08-19 2007-02-22 Microbia, Inc. Compositions et methodes de traitement de troubles gastro-intestinaux
WO2010025510A1 (fr) * 2008-09-03 2010-03-11 Xenome Ltd Bibliothèques de conjugués peptidiques et leurs méthodes de fabrication
WO2011103311A2 (fr) * 2010-02-17 2011-08-25 Ironwood Pharmaceuticals, Inc Traitements de troubles gastro-intestinaux
CA3100941C (fr) * 2011-03-01 2024-03-05 Synergy Pharmaceuticals Inc. Procede de preparation d'agonistes du guanylate cyclase c
EP3718557A3 (fr) * 2013-02-25 2020-10-21 Bausch Health Ireland Limited Agoniste du récepteur de la guanylate cyclase sp-333 à utiliser lors du nettoyage du côlon
EA201592263A1 (ru) * 2013-06-05 2016-05-31 Синерджи Фармасьютикалз, Инк. Ультрачистые агонисты гуанилатциклазы c, способ их получения и использования
WO2016015055A1 (fr) 2014-07-25 2016-01-28 Ironwood Pharmaceuticals, Inc. Compositions de nettoyage du côlon

Also Published As

Publication number Publication date
CA3172777A1 (fr) 2016-11-10
EP3288578B8 (fr) 2023-03-29
FI3288578T3 (fi) 2023-05-03
MA41985A (fr) 2018-03-07
MX2017013928A (es) 2018-01-15
US10618938B2 (en) 2020-04-14
KR102783759B1 (ko) 2025-03-21
EP4218789A2 (fr) 2023-08-02
JP2018519254A (ja) 2018-07-19
JP2022121734A (ja) 2022-08-19
ES2947591T3 (es) 2023-08-11
CA2984437C (fr) 2025-11-18
JP2024015335A (ja) 2024-02-01
EP3288578B1 (fr) 2023-03-15
US20180148476A1 (en) 2018-05-31
CN114716514A (zh) 2022-07-08
WO2016178979A1 (fr) 2016-11-10
CN108040482B (zh) 2022-03-29
JP6930919B2 (ja) 2021-09-01
LT3288578T (lt) 2023-04-25
US20240199697A1 (en) 2024-06-20
EP4218789A3 (fr) 2023-09-27
KR20180005675A (ko) 2018-01-16
HRP20230381T1 (hr) 2023-07-07
EP3288578A1 (fr) 2018-03-07
DK3288578T3 (da) 2023-05-01
RS64160B1 (sr) 2023-05-31
JP2020203954A (ja) 2020-12-24
PT3288578T (pt) 2023-03-28
HUE061954T2 (hu) 2023-09-28
MD3288578T2 (ro) 2023-08-31
CA2984437A1 (fr) 2016-11-10
CN108040482A (zh) 2018-05-15
JP2025169325A (ja) 2025-11-12
SI3288578T1 (sl) 2023-07-31
EA201792401A1 (ru) 2018-05-31
KR20250042844A (ko) 2025-03-27
MX2022013283A (es) 2022-12-13
CY1126031T1 (el) 2023-11-15
DK3288578T5 (da) 2024-10-07
SMT202300114T1 (it) 2023-05-12
PL3288578T3 (pl) 2023-08-14
BR112017023539A2 (pt) 2018-08-14

Similar Documents

Publication Publication Date Title
MX2024008539A (es) Compuestos bifuncionales para degradar la tirosina cinasa de bruton (btk) mediante la trayectoria de ubiquitina proteosoma.
EA201290322A1 (ru) Лечение желудочно-кишечных расстройств
EA201300471A1 (ru) Замещенные 6-аминоникотинамиды в качестве модуляторов kcnq2/3
EA201100062A1 (ru) Соединения и способы модулирования рецепторов, связанных с белком g
EA201170036A1 (ru) Соединения боронатного эфира и его фармацевтические составы
EA200901032A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
EA201390803A1 (ru) Ингибиторы бромодомена и их применение
EP1881823A4 (fr) Compositions et procedes pour le traitement des troubles oculaires
EA200970337A1 (ru) Ингибиторы котранспортера натрий-глюкозы 2 и способы их применения
MA44426B1 (fr) Compositions et méthodes pour diminier l'expression de tau
ATE530540T1 (de) Pyrimidonverbindungen als gsk-3-inhibitoren
EA201071291A3 (ru) Nmda рецепторные антагонисты для лечения нейропсихиатрических расстройств
EA200602062A1 (ru) Амидосоединения и их применение в качестве фармацевтических средств
NO20090157L (no) Tienpyrimidiner anvendelige som modulatorer av ionekanaler
EA201790653A1 (ru) Способ лечения болезни альцгеймера и других расстройств
EA201290860A1 (ru) Лечение ревматоидного артрита комбинацией лаквинимода и метотрексата
MX2022000712A (es) Moduladores de nlrp3.
MA44935A1 (fr) Compositions pharmaceutiques contenant un antagoniste de l'intégrine alpha 4 , utilisée pour le traitement d"affections inflammatoires oculaires
CL2011002766A1 (es) Compuestos derivados de carboxamida, inhibidores de calpaina; composicion farmaceutica que los comprende; y su uso en el tratamiento de enfermedades neurodegenerativas, alzahimer, dolor, entre otras.
ATE472998T1 (de) Kationische liposomale zubereitungen zur behandlung von rheumatoider arthritis
EA202192925A1 (ru) Твердые формы ингибитора glyt1
ATE527243T1 (de) Calciumkanal-antagonisten vom typ chinazolinon t
EA201171035A1 (ru) Композиции, включающие модуляторы pde4, и способ их применения для лечения, профилактики и сопровождения туберкулеза
EA202190057A1 (ru) Солюбилизированные апиразы, способы и применение
BRPI0907220A2 (pt) métodos de tratar distúrbios de perda óssea usando um antagonista de gm-csf